価格表

在庫・価格 : 2026年04月14日 19時57分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
OVA mRNA, Modified, N1-Methyl-Pseudouridine(N1-mψ)
データシート
MRNA40-100 OZBオズ バイオサイエンス
OZ Biosciences
100 μg ¥131,000
(未発注)
追加

在庫・価格 : 2026年04月14日 19時57分 現在

OVA mRNA, Modified, N1-Methyl-Pseudouridine(N1-mψ)

  • 商品コード:MRNA40-100
  • メーカー:OZB
  • 包装:100μg
  • 価格: ¥131,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Hussain M., RSC Pharma. 2025 doi.org/10.1039/D5PM00150A

PubMed
2 Hussain M., Vaccines 2025 Vaccines 2025, 13(4), 370

PubMed
3 Coleman HJ et al. Lipid-free, thermostable mRNA vaccines prepared using atomic layer deposition. J Pharm Sci 2026 Feb;115(2):104066
Coleman HJ et al
2026/01/01
PubMed
4 Binici B et al. A comparative study of cationic lipid-enriched LNPs for mRNA vaccine delivery. Int J Pharm 2025 Sep;682:125941
Binici B et al
2025/01/01
PubMed
5 Hassanel DNBP et al. Replacing poly(ethylene glycol) with RAFT lipopolymers in mRNA lipid nanoparticle systems for effective gene delivery. Int J Pharm 2024 Nov;665:124695
Hassanel DNBP et al
2024/01/01
PubMed
6 Tai JA et al. Immunogenic Comparison of Nucleic Acid-Based Vaccines Administered by Pyro-Drive Jet Injector. Vaccines (Basel) 2024 Jul;12(7)
Tai JA et al
2024/01/01
PubMed
7 Binici B et al. The Role of Biological Sex in Pre-Clinical (Mouse) mRNA Vaccine Studies. Vaccines (Basel) 2024 Mar;12(3)
Binici B et al
2024/01/01
PubMed
8 Jeger-Madiot R et al. Modeling memory B cell responses in a lymphoid organ-chip to evaluate mRNA vaccine boosting. J Exp Med 2024 Oct;221(10)
Jeger-Madiot R et al
2024/01/01
PubMed
  • No.: 1
  • 文献情報:
    Hussain M., RSC Pharma. 2025 doi.org/10.1039/D5PM00150A

  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Hussain M., Vaccines 2025 Vaccines 2025, 13(4), 370

  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Coleman HJ et al. Lipid-free, thermostable mRNA vaccines prepared using atomic layer deposition. J Pharm Sci 2026 Feb;115(2):104066
    Coleman HJ et al
    2026/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Binici B et al. A comparative study of cationic lipid-enriched LNPs for mRNA vaccine delivery. Int J Pharm 2025 Sep;682:125941
    Binici B et al
    2025/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Hassanel DNBP et al. Replacing poly(ethylene glycol) with RAFT lipopolymers in mRNA lipid nanoparticle systems for effective gene delivery. Int J Pharm 2024 Nov;665:124695
    Hassanel DNBP et al
    2024/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Tai JA et al. Immunogenic Comparison of Nucleic Acid-Based Vaccines Administered by Pyro-Drive Jet Injector. Vaccines (Basel) 2024 Jul;12(7)
    Tai JA et al
    2024/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Binici B et al. The Role of Biological Sex in Pre-Clinical (Mouse) mRNA Vaccine Studies. Vaccines (Basel) 2024 Mar;12(3)
    Binici B et al
    2024/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Jeger-Madiot R et al. Modeling memory B cell responses in a lymphoid organ-chip to evaluate mRNA vaccine boosting. J Exp Med 2024 Oct;221(10)
    Jeger-Madiot R et al
    2024/01/01
  • 備考:
  • 参照:
    PubMed